John Varian's most recent trade in SELLAS Life Sciences Group Inc was a trade of 18,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 12,500 | 22,900 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 6,000 | 10,400 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 2,500 | 4,400 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 7,125 | 7,125 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 1,900 | 1,900 (0%) | 0% | 0 | Common Stock |